CDXS vs REGN: Which Stock is Better?
Side-by-side comparison of Codexis Inc and Regeneron Pharmaceuticals Inc in 2026
CDXS
Codexis Inc
$2.59
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | CDXS | REGN | Winner |
|---|---|---|---|
| Market Cap | $230.81M | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.8% | 0.0% | CDXS |
| Gross Margin | 12.4% | 44.6% | REGN |
Analyze CDXS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXS or REGN a better investment?
Comparing CDXS and REGN: Codexis Inc has a market cap of $230.81M while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXS and REGN?
CDXS (Codexis Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXS or REGN?
CDXS has higher revenue growth at 0.8% vs 0.0% for REGN.
Which company is more profitable: CDXS or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 12.4% for CDXS.
Which is the larger company: CDXS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $230.81M for CDXS.
Should I buy CDXS or REGN in 2026?
Both CDXS and REGN have investment merit. CDXS trades at $2.59 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXS and REGN stock?
Key differences: Market Cap ($230.81M vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.8% vs 0.0%), Gross Margin (12.4% vs 44.6%).